Related Experiment Video
Updated: Aug 2, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Analysis of autoantibody epitopes on steroid 21-hydroxylase using a panel of monoclonal antibodies
S Chen1, J Sawicka, L Prentice
1FIRS Laboratories, RSR Limited, Cardiff, Wales, United Kingdom.
Abstract:
A panel of five mouse monoclonal antibodies (MAbs) to human recombinant steroid 21-hydroxylase (21-OH) were produced, characterized, and used to study the interaction of 21-OH autoantibodies (AAbs) with different epitopes on human 21-OH. AAbs in patients with isolated autoimmune Addison's disease, autoimmune polyglandular syndromes types I and II, and 21-OH antibody-positive patients without overt Addison's disease (25 patients in total) were studied. Four MAbs were IgG1 subclass, one was IgG2a, and all had kappa light chains. The affinities of four of the antibodies were in the range 2.0 x 10(8) M(-1) to 7.0 x 10(8) M(-1), and the affinity of the other was 2.3 x 10(7) M(-1) 21-OH MAbs did not cross-react with 17alpha-hydroxylase (17alpha-OH)) or P450 side chain cleavage enzyme. Studies using a series of 21-OH fragments allowed the identification of short stretches of amino acids (AA) that were involved in forming the MAb binding sites. AA 391-405, defined as epitope region (ER) 1, were found to be important for binding of M21-OH1 and M21-OH2, AA 406-411 (ER2) were important for M21-OH3 and M21-OH4 binding, and AA 335-339 (ER3) for M21-OH5 binding. In addition, MAb Fab or F(ab')2 fragments were used to study 21-OH AAb epitopes in competition experiments. These investigations demonstrated that 21-OH AAbs recognize similar epitopes to the MAbs, with ER2 and ER3 being part of two distinct major epitopes, and ER 1 being part of a minor epitope. Mixtures of M21-OH antibody Fab or F(ab')2 fragments caused almost complete inhibition (80%-95%) of AAb binding in 24 out of 25 sera, and in the case of the remaining serum, the effect was marked but incomplete (67% inhibition). There were no major differences between the binding characteristics of AAbs from patients with different forms of autoimmune adrenal disease. All five 21-OH MAbs reacted with human adrenal tissue in an immunofluorescence test, but only M21-OH1 and M21-OH2 reacted with bovine adrenal tissue in these experiments. None of the MAbs reacted with human ovarian tissue in an immunofluorescence test. Overall, these studies indicate that 21-OH AAbs bind to at least three different epitopes in the C-terminal part of 21-OH, and two of these epitopes appear to be human 21-OH specific.
Insights
This study characterized mouse monoclonal antibodies to steroid 21-hydroxylase (21-OH) and found that autoantibodies in patients with autoimmune adrenal diseases recognize at least three distinct epitopes on 21-OH, with two being human-specific.
Area of Science:
- Immunology
- Endocrinology
- Autoimmunity
Background:
- Steroid 21-hydroxylase (21-OH) is a key enzyme in cortisol synthesis.
- Autoantibodies to 21-OH are associated with autoimmune Addison's disease and related conditions.
- Understanding the epitopes recognized by these autoantibodies is crucial for disease diagnosis and management.
Purpose of the Study:
- To produce and characterize monoclonal antibodies (MAbs) against human recombinant 21-OH.
- To investigate the epitopes recognized by autoantibodies (AAbs) in patients with autoimmune adrenal diseases.
- To determine if these epitopes are specific to human 21-OH.
Main Methods:
- Production and characterization of five mouse monoclonal antibodies to human 21-OH.
- Affinity determination and epitope mapping using 21-OH fragments and competition assays.
- Immunofluorescence studies on human and bovine adrenal tissues, and human ovarian tissue.
Main Results:
- The five MAbs recognized distinct epitope regions (ER1, ER2, ER3) on 21-OH.
- Patient AAbs recognized similar epitopes to the MAbs, with ER2 and ER3 representing major epitopes and ER1 a minor one.
- AAbs from different autoimmune adrenal disease forms showed no major differences in binding characteristics.
- Two of the identified epitopes were specific to human 21-OH.
Conclusions:
- Human 21-OH autoantibodies target at least three distinct epitopes in the C-terminal region of the enzyme.
- Two of these epitopes are specific to human 21-OH, suggesting potential for human-specific diagnostic or therapeutic targets.
- The findings advance our understanding of the immunopathology of autoimmune adrenal diseases.

